对使用大麻二酚的了解和看法

Abigail Calleja, Janis Vella Szijj, A. Serracino-Inglott, L. Azzopardi
{"title":"对使用大麻二酚的了解和看法","authors":"Abigail Calleja, Janis Vella Szijj, A. Serracino-Inglott, L. Azzopardi","doi":"10.22270/jddt.v14i1.6266","DOIUrl":null,"url":null,"abstract":"Background: Cannabidiol (CBD) is one of the main cannabinoids present in the cannabis plant. The demand for CBD grew over time with more individuals consuming CBD products due to its potential therapeutic properties. Objectives: To assess the knowledge and perceptions of Maltese members of the public and health care professionals (HCPs) about CBD, one of the main cannabinoids present in the cannabis plant. Methods: Surveys aiming to assess the knowledge and perception of the public and HCPs about CBD were developed, validated and disseminated. Results: Four hundred members of the public and 150 HCPs completed questionnaires. Ninety-six percent of participants (n=384) agreed that CBD has a therapeutic effect. Respondents from the general public were mostly knowledgeable about CBD and its use, had positive perceptions in relation to CBD and like HCPs, feel more comfortable if CBD is recommended by HCPs. HCPs were not so knowledgeable about certain aspects on CBD. One hundred and twelve HCPs were not aware that there is only one FDA/EMA approved CBD-based product. HCPs would feel comfortable in prescribing CBD products for pain and insomnia and the majority of them (55%; n=83) believe that CBD has mostly an analgesic effect. Social stigma associated with the use of CBD and potential judgement of HCPs were barriers to CBD use. Conclusion: Increased research, knowledge and availability of prescribing information and guidelines related CBD use might lead to an increased willingness of HCPs to recommend CBD and lead to a decrease in potential barriers associated with its use. \nKeywords: Cannabidiol, positive perceptions, pain and insomnia","PeriodicalId":506928,"journal":{"name":"Journal of Drug Delivery and Therapeutics","volume":"116 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Knowledge and perceptions about Cannabidiol use\",\"authors\":\"Abigail Calleja, Janis Vella Szijj, A. Serracino-Inglott, L. Azzopardi\",\"doi\":\"10.22270/jddt.v14i1.6266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Cannabidiol (CBD) is one of the main cannabinoids present in the cannabis plant. The demand for CBD grew over time with more individuals consuming CBD products due to its potential therapeutic properties. Objectives: To assess the knowledge and perceptions of Maltese members of the public and health care professionals (HCPs) about CBD, one of the main cannabinoids present in the cannabis plant. Methods: Surveys aiming to assess the knowledge and perception of the public and HCPs about CBD were developed, validated and disseminated. Results: Four hundred members of the public and 150 HCPs completed questionnaires. Ninety-six percent of participants (n=384) agreed that CBD has a therapeutic effect. Respondents from the general public were mostly knowledgeable about CBD and its use, had positive perceptions in relation to CBD and like HCPs, feel more comfortable if CBD is recommended by HCPs. HCPs were not so knowledgeable about certain aspects on CBD. One hundred and twelve HCPs were not aware that there is only one FDA/EMA approved CBD-based product. HCPs would feel comfortable in prescribing CBD products for pain and insomnia and the majority of them (55%; n=83) believe that CBD has mostly an analgesic effect. Social stigma associated with the use of CBD and potential judgement of HCPs were barriers to CBD use. Conclusion: Increased research, knowledge and availability of prescribing information and guidelines related CBD use might lead to an increased willingness of HCPs to recommend CBD and lead to a decrease in potential barriers associated with its use. \\nKeywords: Cannabidiol, positive perceptions, pain and insomnia\",\"PeriodicalId\":506928,\"journal\":{\"name\":\"Journal of Drug Delivery and Therapeutics\",\"volume\":\"116 22\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drug Delivery and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22270/jddt.v14i1.6266\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Delivery and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22270/jddt.v14i1.6266","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:大麻二酚(CBD)是存在于大麻植物中的主要大麻素之一。随着时间的推移,人们对 CBD 的需求越来越大,越来越多的人因其潜在的治疗特性而消费 CBD 产品。目标:评估马耳他公众和医疗保健专业人员(HCPs)对 CBD(大麻植物中的主要大麻素之一)的了解和看法。调查方法制定、验证并分发旨在评估公众和保健专业人员对 CBD 的了解和看法的调查问卷。结果:400 名公众和 150 名保健医生填写了调查问卷。96%的参与者(n=384)同意CBD具有治疗作用。公众受访者大多了解 CBD 及其使用,对 CBD 有积极的看法,并且与保健医生一样,对保健医生推荐 CBD 感到更放心。而保健医生则对CBD的某些方面不太了解。有 112 名主治医师不知道只有一种 CBD 产品获得了美国食品及药物管理局(FDA/EMA)的批准。主治医师对处方治疗疼痛和失眠的 CBD 产品感到满意,其中大多数(55%;n=83)认为 CBD 主要有镇痛作用。与使用 CBD 相关的社会耻辱感和主治医生的潜在判断是使用 CBD 的障碍。结论加强与使用 CBD 相关的研究、知识、处方信息和指南的可用性,可能会提高主治医生推荐 CBD 的意愿,并减少与使用 CBD 相关的潜在障碍。关键词大麻二酚、积极认知、疼痛和失眠
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Knowledge and perceptions about Cannabidiol use
Background: Cannabidiol (CBD) is one of the main cannabinoids present in the cannabis plant. The demand for CBD grew over time with more individuals consuming CBD products due to its potential therapeutic properties. Objectives: To assess the knowledge and perceptions of Maltese members of the public and health care professionals (HCPs) about CBD, one of the main cannabinoids present in the cannabis plant. Methods: Surveys aiming to assess the knowledge and perception of the public and HCPs about CBD were developed, validated and disseminated. Results: Four hundred members of the public and 150 HCPs completed questionnaires. Ninety-six percent of participants (n=384) agreed that CBD has a therapeutic effect. Respondents from the general public were mostly knowledgeable about CBD and its use, had positive perceptions in relation to CBD and like HCPs, feel more comfortable if CBD is recommended by HCPs. HCPs were not so knowledgeable about certain aspects on CBD. One hundred and twelve HCPs were not aware that there is only one FDA/EMA approved CBD-based product. HCPs would feel comfortable in prescribing CBD products for pain and insomnia and the majority of them (55%; n=83) believe that CBD has mostly an analgesic effect. Social stigma associated with the use of CBD and potential judgement of HCPs were barriers to CBD use. Conclusion: Increased research, knowledge and availability of prescribing information and guidelines related CBD use might lead to an increased willingness of HCPs to recommend CBD and lead to a decrease in potential barriers associated with its use. Keywords: Cannabidiol, positive perceptions, pain and insomnia
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Relationship between antibody titer than the Incidence of Infection After Complete Dose of COVID-19 Astrazeneca Vaccination Based on Sociodemographics A Basic Review on Hypertension, its Non-Pharmacological and Pharmacological Treatment Formulation and Evaluation of Moxifloxacin Hydrochloride Loaded Cubosomal Gel for Ocular Delivery Design, Synthesis, Characterization and Biological Evaluation of Novel Depsides as Potential Antibacterials Synthesis and characterizations of Hg (II) Complex of Macrocyclic complexes compounds Tetradecahydrodibenzo hexaazacyclooctadecine with HgX2 (X= Cl, Br) by Hirshfeld analysis and antimicrobial activity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1